RBC Out With Note On QuidelOrtho Saying "After Speaking To Management No Change At QuidelOrtho; Company Withdraws Original Savanna RVP4+ Assay From FDA 510(k) Submission, Plans Resubmission Ahead Of 2024/2025 Respiratory Season
加拿大皇家银行在QuideLortho上发表了关于QuideLortho的说明说:“在与管理层交谈后,QuideLortho没有变化;公司从FDA提交的510(k)文件中撤回了最初的稀树草原RVP4+检测,计划在2024/2025年呼吸季节之前重新提交